These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 11655034

  • 21. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V.
    New Sci; 1996 Jun 08; 150(2033):10. PubMed ID: 11656540
    [No Abstract] [Full Text] [Related]

  • 22. Commission says institutional review boards should change procedures now.
    Maloney DM.
    Hum Res Rep; 1999 Jan 08; 14(1):1-2. PubMed ID: 11657555
    [No Abstract] [Full Text] [Related]

  • 23. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ.
    IRB; 1987 Jan 08; 9(4):1-4. PubMed ID: 11649946
    [No Abstract] [Full Text] [Related]

  • 24. OPRR and FDA propose revised expedited review categories.
    McGough H.
    IRB; 1998 Jan 08; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract] [Full Text] [Related]

  • 25. The impact of institutional review boards on clinical research.
    Levine RJ.
    Perspect Biol Med; 1998 Jan 08; 23(2):. PubMed ID: 11663073
    [No Abstract] [Full Text] [Related]

  • 26. Institutional review boards now given explicit responsibility in new federal rule.
    Maloney DM.
    Hum Res Rep; 1995 Feb 08; 10(2):1-2. PubMed ID: 11654158
    [No Abstract] [Full Text] [Related]

  • 27. Annual review: observed deficiencies and suggested corrections.
    Adams MS, Conrad DA.
    IRB; 1996 Feb 08; 18(6):1-4. PubMed ID: 11654743
    [No Abstract] [Full Text] [Related]

  • 28. Regulation of clinical research: who's protecting who from what?
    Petricciani JC.
    Food Drug Cosmet Law J; 1979 Apr 08; 34(4):205-7. PubMed ID: 11661718
    [No Abstract] [Full Text] [Related]

  • 29. Ethics in neurobiological research with human subjects -- final reflections.
    Katz J.
    Account Res; 1996 Apr 08; 4(3-4):277-83. PubMed ID: 11654523
    [No Abstract] [Full Text] [Related]

  • 30. An even safer safety net.
    Prentice E.
    Hastings Cent Rep; 1997 Apr 08; 27(3):46. PubMed ID: 11644996
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The FDA's final regulations: IRBs and medical devices.
    Holder AR.
    IRB; 1980 Apr 08; 2(6):1-4. PubMed ID: 11661803
    [No Abstract] [Full Text] [Related]

  • 36. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL.
    IRB; 1983 Apr 08; 5(1):6-9. PubMed ID: 11649511
    [No Abstract] [Full Text] [Related]

  • 37. An overview of FDA, IRBs and regulations.
    Petricciani JC.
    IRB; 1981 Dec 08; 3(10):1-3, 11. PubMed ID: 11649413
    [No Abstract] [Full Text] [Related]

  • 38. Report says institutional review boards are conducting inadequate reviews.
    Maloney DM.
    Hum Res Rep; 1998 Sep 08; 13(9):1-2. PubMed ID: 11660603
    [No Abstract] [Full Text] [Related]

  • 39. Informed consent to participate in research: Part II.
    Levine RJ.
    Bioethics Dig; 1977 Apr 08; 1(12):1-16. PubMed ID: 11664810
    [No Abstract] [Full Text] [Related]

  • 40. Agency's final rule covers confidentiality in research.
    Maloney DM.
    Hum Res Rep; 1996 Feb 08; 11(2):2. PubMed ID: 11654436
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.